Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromogranins | 6 | 2022 | 86 | 0.970 |
Why?
|
| Vascular Endothelial Growth Factor A | 11 | 2024 | 1579 | 0.760 |
Why?
|
| Ischemia | 4 | 2016 | 403 | 0.750 |
Why?
|
| Choroidal Neovascularization | 4 | 2024 | 30 | 0.690 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 153 | 0.660 |
Why?
|
| Genetic Therapy | 4 | 2024 | 1714 | 0.610 |
Why?
|
| Regeneration | 3 | 2016 | 283 | 0.610 |
Why?
|
| Hindlimb | 3 | 2016 | 111 | 0.590 |
Why?
|
| Retinopathy of Prematurity | 3 | 2022 | 58 | 0.570 |
Why?
|
| Neovascularization, Pathologic | 6 | 2022 | 1585 | 0.550 |
Why?
|
| Femoral Artery | 1 | 2016 | 197 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 9 | 2021 | 345 | 0.430 |
Why?
|
| Retinal Neovascularization | 3 | 2022 | 19 | 0.400 |
Why?
|
| Oxygen | 4 | 2022 | 792 | 0.350 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2016 | 205 | 0.340 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2024 | 1267 | 0.300 |
Why?
|
| Dependovirus | 2 | 2024 | 142 | 0.290 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2024 | 169 | 0.290 |
Why?
|
| Retinal Vessels | 3 | 2023 | 82 | 0.270 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 353 | 0.260 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2017 | 105 | 0.260 |
Why?
|
| Nephritis, Hereditary | 2 | 2022 | 51 | 0.240 |
Why?
|
| Collagen Type IV | 2 | 2022 | 107 | 0.240 |
Why?
|
| Laminin | 1 | 2024 | 209 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 1291 | 0.230 |
Why?
|
| Genetic Vectors | 4 | 2024 | 1857 | 0.220 |
Why?
|
| Cell Movement | 5 | 2024 | 2472 | 0.220 |
Why?
|
| Autoantigens | 2 | 2022 | 248 | 0.220 |
Why?
|
| Animals | 28 | 2024 | 62045 | 0.220 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 303 | 0.210 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 14 | 0.210 |
Why?
|
| Drug Combinations | 1 | 2024 | 634 | 0.210 |
Why?
|
| Antibodies | 2 | 2021 | 809 | 0.210 |
Why?
|
| Macular Degeneration | 1 | 2024 | 117 | 0.200 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 661 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 7103 | 0.200 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 7383 | 0.200 |
Why?
|
| Signal Transduction | 7 | 2022 | 12102 | 0.200 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 218 | 0.190 |
Why?
|
| Collagen | 1 | 2024 | 726 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 518 | 0.180 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Mitochondria | 2 | 2019 | 1299 | 0.170 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2019 | 16 | 0.170 |
Why?
|
| Retina | 5 | 2023 | 539 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2021 | 190 | 0.160 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 703 | 0.160 |
Why?
|
| Osteopontin | 1 | 2019 | 145 | 0.160 |
Why?
|
| Mice | 17 | 2024 | 35594 | 0.160 |
Why?
|
| Reperfusion | 1 | 2016 | 25 | 0.140 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2016 | 17 | 0.130 |
Why?
|
| Adenoviridae | 2 | 2016 | 1497 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 2455 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 400 | 0.130 |
Why?
|
| Glucuronidase | 1 | 2015 | 54 | 0.120 |
Why?
|
| Gene Silencing | 2 | 2016 | 827 | 0.120 |
Why?
|
| Proteomics | 1 | 2022 | 1427 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 226 | 0.120 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2014 | 12 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2015 | 128 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2013 | 912 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2024 | 1642 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 266 | 0.110 |
Why?
|
| Receptors, CXCR4 | 2 | 2014 | 276 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2013 | 51 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 804 | 0.110 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 145 | 0.110 |
Why?
|
| Leptin | 1 | 2014 | 306 | 0.110 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 266 | 0.100 |
Why?
|
| Myocardium | 2 | 2019 | 1233 | 0.100 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2022 | 93 | 0.100 |
Why?
|
| Hypoxia | 1 | 2014 | 472 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2022 | 5731 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 628 | 0.100 |
Why?
|
| Intravitreal Injections | 2 | 2022 | 143 | 0.100 |
Why?
|
| Nicotine | 1 | 2013 | 265 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2024 | 7237 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2016 | 1309 | 0.090 |
Why?
|
| Endometrium | 1 | 2013 | 460 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 361 | 0.080 |
Why?
|
| Stem Cells | 2 | 2013 | 1217 | 0.080 |
Why?
|
| Heart Failure | 1 | 2022 | 2333 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2023 | 1038 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2017 | 2100 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 40 | 0.080 |
Why?
|
| Cytokines | 1 | 2017 | 2826 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2021 | 1372 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2015 | 1811 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1352 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 494 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2016 | 5697 | 0.070 |
Why?
|
| Apoptosis | 4 | 2016 | 7754 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 1757 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Humans | 18 | 2024 | 270744 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 1006 | 0.060 |
Why?
|
| Anisomycin | 1 | 2004 | 12 | 0.060 |
Why?
|
| Antimycin A | 1 | 2004 | 13 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2004 | 15 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 46 | 0.060 |
Why?
|
| Electron Transport | 1 | 2004 | 78 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 470 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 110 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 3439 | 0.060 |
Why?
|
| Angiography | 1 | 2005 | 350 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2024 | 278 | 0.060 |
Why?
|
| Rabbits | 1 | 2005 | 1028 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2024 | 246 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 223 | 0.060 |
Why?
|
| Cell Line | 4 | 2015 | 5339 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 2886 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 419 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2016 | 4943 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2004 | 282 | 0.050 |
Why?
|
| Capillaries | 1 | 2022 | 98 | 0.050 |
Why?
|
| Cellular Senescence | 2 | 2016 | 389 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2013 | 220 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2021 | 135 | 0.050 |
Why?
|
| Rats | 2 | 2013 | 6525 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 879 | 0.050 |
Why?
|
| Cholesterol | 1 | 2024 | 659 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 2212 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 809 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 329 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 885 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 544 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2015 | 968 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 3063 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 1017 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 1469 | 0.040 |
Why?
|
| Secretory Vesicles | 1 | 2017 | 41 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 1838 | 0.030 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2016 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 5070 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 220 | 0.030 |
Why?
|
| Receptors, Neuropeptide | 1 | 2016 | 27 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 733 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 168 | 0.030 |
Why?
|
| Transfection | 2 | 2013 | 3118 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 248 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 318 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2005 | 2651 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 64 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2014 | 74 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 639 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2014 | 128 | 0.030 |
Why?
|
| Foam Cells | 1 | 2013 | 27 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 42 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 90 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 3408 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1149 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 198 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1042 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2013 | 223 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 153 | 0.020 |
Why?
|
| Female | 6 | 2022 | 148945 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 200 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 402 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 13021 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2091 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 591 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 6516 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 4134 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 2454 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 1525 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 522 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2073 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 3028 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 5437 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 1280 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 1136 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 1387 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 1074 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8696 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 1051 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 3485 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1585 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 192 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 2422 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 3642 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3045 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 460 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2008 | 275 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 737 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 2115 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 33733 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 693 | 0.020 |
Why?
|
| Male | 3 | 2022 | 128374 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1588 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 1366 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 2196 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6192 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 4212 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 16205 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 5149 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 4961 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 3919 | 0.010 |
Why?
|